<unk>  is indicated for the treatment of moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP).
Dupilumab
Olaratumab
Emapalumab
Ustekinumab
Evolocumab
Burosumab
Sarilumab
Evinacumab